HART HEALTH PARTNERSHIP — All Prescriptions & Medications
Practice Code: J82110 | FLEET, GU51 4PE
Over the last 12 months, HART HEALTH PARTNERSHIP prescribed 350,567 items across 752 different medications at a total cost of £4,012,050 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mebeverine hydrochloride compound preparations | 10 | 910 | £792 | -11.6% ▼ |
| Olsalazine sodium | 10 | 2,240 | £2.9K | -0.4% vs avg |
| Amiloride hydrochloride | 10 | 532 | £257 | -60.3% ▼ |
| Raloxifene hydrochloride | 10 | 672 | £95 | -32.3% ▼ |
| Triptorelin | 10 | 10 | £2.0K | -52.6% ▼ |
| Sodium fluoride | 10 | 1,218 | £120 | -69.9% ▼ |
| Powder 4.6 kcal/g peptide based formula (0913091) | 10 | 15.2K | £942 | +58.7% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 10 | 420.0K | £7.9K | +12.1% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 10 | 141.5K | £4.6K | +12.5% ▲ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 10 | 6,022 | £922 | +3.7% ▲ |
| Febuxostat | 10 | 504 | £58 | -73.2% ▼ |
| Diethylamine salicylate | 10 | 1,000 | £31 | -63.0% ▼ |
| Hydrocort sodiumphos | 10 | 420 | £146 | +30.6% ▲ |
| Budesonide | 10 | 14 | £145 | -35.7% ▼ |
| Gamolenic acid | 10 | 1,200 | £218 | -3.2% ▼ |
| 10 | 54 | £120 | -69.1% ▼ | |
| 10 | 400 | £797 | -77.3% ▼ | |
| 10 | 700 | £199 | -32.0% ▼ | |
| 10 | 17 | £304 | +47.0% ▲ | |
| 10 | 390 | £145 | +34.3% ▲ | |
| 10 | 390 | £1.2K | -17.9% ▼ | |
| 10 | 440 | £2.1K | -0.7% vs avg | |
| 10 | 200 | £763 | -34.3% ▼ | |
| 10 | 190 | £690 | +33.4% ▲ | |
| 10 | 160 | £973 | -13.1% ▼ | |
| Sodium citrate (Rectal) | 11 | 107 | £70 | -20.3% ▼ |
| Disopyramide | 11 | 2,016 | £323 | +70.8% ▲ |
| Aclidinium bromide/formoterol | 11 | 12 | £371 | -68.7% ▼ |
| Midazolam hydrochloride | 11 | 46 | £1.0K | -23.7% ▼ |
| Colistimethate sodium | 11 | 660 | £1.2K | -2.7% ▼ |
| Biphasic insulin lispro | 11 | 60 | £372 | -74.4% ▼ |
| Metformin hydrochloride/sitagliptin | 11 | 1,064 | £447 | -70.6% ▼ |
| Testosterone enantate | 11 | 33 | £1.1K | +54.0% ▲ |
| Exemestane | 11 | 514 | £101 | -66.1% ▼ |
| Levofloxacin | 11 | 55 | £88 | +159.2% ▲ |
| Ciprofloxacin | 11 | 65 | £58 | +38.4% ▲ |
| Heparinoid | 11 | 550 | £42 | -15.7% ▼ |
| Lidocaine | 11 | 270 | £191 | -4.3% ▼ |
| 11 | 110 | £486 | +27.9% ▲ | |
| 11 | 27 | £904 | +118.6% ▲ | |
| 11 | 840 | £470 | -43.1% ▼ | |
| 11 | 630 | £425 | +76.4% ▲ | |
| 11 | 2,150 | £319 | -5.8% ▼ | |
| 11 | 990 | £2.8K | +73.0% ▲ | |
| 11 | 1,000 | £111 | +64.4% ▲ | |
| 11 | 1,000 | £95 | +7.5% ▲ | |
| 11 | 630 | £2.2K | -7.1% ▼ | |
| 11 | 690 | £298 | -37.0% ▼ | |
| Dalteparin sodium | 12 | 240 | £655 | -27.4% ▼ |
| Prasugrel | 12 | 672 | £92 | -61.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.